Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2003
11/26/2003EP0988043B1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis
11/26/2003EP0927177B1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458974A Stimulation of cartilage growth with agonists of non-protecolytically activated thrombin receptor
11/26/2003CN1458935A Integrain binding motif containing peptides and methods of treating skeletal diseases
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458158A Biphosphonate
11/26/2003CN1457868A Naturally curing fracture setting pill
11/26/2003CN1457861A Analgesic paste for hyperosteogeny, necrosis and cervical vertebrae disease
11/26/2003CN1457852A Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method
11/26/2003CN1457845A Medicinal wine for curing old injury recurrent pain
11/26/2003CN1457835A Draqon's blood dripping pill for removing blood stasis and killing pain, arresting bleeding and promoting granulation and its preparing method
11/26/2003CN1457826A Capsule for killing pain and recovery
11/26/2003CN1457822A Medicine for preventing and treating bone fracture and osteoporosis
11/26/2003CN1457821A Medicine for curing aseptic necrosis of head of femur
11/26/2003CN1457820A Pill for eliminating stagnation and pains
11/26/2003CN1457813A Medicine for curing rheumatism and traumatic injury
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128631C External-use medicinal plaster for curing bone disease
11/26/2003CN1128613C Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio- and post menopansal woman
11/26/2003CN1128612C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
11/25/2003US6653493 Lipoxin compounds and their use in treating cell proliferative disorders
11/25/2003US6653476 Thienopyridine derivatives, their production and use
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653350 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
11/25/2003US6653347 For therapy
11/25/2003US6653322 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6652876 Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003US6652854 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening
11/25/2003CA2105014C Imidazolidine derivatives
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095607A2 Role of p62 in aging-related disease
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095451A1 Carbamate-substituted pyrazolopyridines
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095029A1 Bisphosphonic acid for the treatment and prevention of osteoporosis
11/20/2003WO2003094991A1 Medical products comprising a haemocompatible coating, production and use thereof
11/20/2003WO2003094990A1 Compounds and method for coating surfaces in a haemocompatible manner
11/20/2003WO2003094984A1 Bone outgrowth agent and therapeutic agent for osteoporosis
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094947A1 Herbal extract for prophylaxis or treatment of inflammatory diseases and process for preparation thereof
11/20/2003WO2003094940A1 Medicament for prevention and treatment of fracture and osteoporosis
11/20/2003WO2003094932A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003WO2003094925A1 Injectable bisphosphonate formulations
11/20/2003WO2003094910A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/20/2003WO2003094617A2 Use of vegf for treating bone defects
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003065971A9 Non-myeloablative tolerogenic treatment with tyrphostins
11/20/2003WO2003061565A3 Use of calmodulin to promote bone regeneration
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003040399A3 Therapeutic methods for nucleic acid delivery vehicles
11/20/2003WO2003038110A3 7118, a human arginine n-methyltransferase family member and uses therefor
11/20/2003WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002032407A3 Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216481 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse
11/20/2003US20030216463 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
11/20/2003US20030216462 Anticancer agents; psoriasis
11/20/2003US20030216446 Aryl ureas as kinase inhibitors
11/20/2003US20030216445 Osteoporosis; immunosuppressants; wound healing agent
11/20/2003US20030216440 Process for preparing arylacetylaminothiazoles
11/20/2003US20030216428 Sexual disorders; blood disorders; osteoporosis; bone disorders
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216406 Pyrimidine derivatives
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216368 Hormone replacement therapy
11/20/2003US20030216367 In perimenopausal, menopausal, and postmenopausal women through the sequential administration of combinations of conjugated estrogens and trimegestone
11/20/2003US20030216356 Cause the selective destruction of tumour vasculature; are used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216328 Androgen derivatives and uses thereof
11/20/2003US20030216314 Methods of reducing angiogenesis
11/20/2003US20030216297 Pharmaceutical composition
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
1 ... 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 ... 820